Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585117 · ClinicalTrials.gov registry record · NA
Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients
A NA study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT00585117: Clinical Trial NA study, sponsored by University of Wisconsin, Madison.
NCT00585117 is a NA study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00585117, a NA study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Hypoxia is a key factor in malignant progression of a neoplasm. It is our aim to explore the basis for quantitative in vivo tumor imaging by Cu-61 diacetyl-bis(N4-methylthiosemicarbazone)PET imaging as a surrogate of tissue hypoxia. We hypothesize that the hypoxia levels are predictive of the tumor response to therapy. Patients will have 2 CU-ATSM PET scans done and the goal is to show spatially stable tracer distributions that correlate with tumor hypoxia. This study will serve as a pilot study for a PO1 submission
Interventions
- PROCEDURE PET Imaging
- PROCEDURE PET imaging
- PROCEDURE PET-imaging with CuATSM
- PROCEDURE PET CuATSM
- PROCEDURE PET imaging with CuATSM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2006-12 |
| Est. Completion | 2012-01 |
| Phase | NA |
Why NCT00585117 stopped before completion
NCT00585117 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which PET Imaging is the first listed.
NCT00585117 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00585117 about?
NCT00585117 is a clinical study titled "Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients". Hypoxia is a key factor in malignant progression of a neoplasm. It is our aim to explore the basis for quantitative in vivo tumor imaging by Cu-61 diacetyl-bis(N4-methylthiosemicarbazone)PET imaging as a surrogate of tissue hypoxia. We hypothesize that the hypoxia levels are predictive of the tumor ...
What is the current status of trial NCT00585117?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2006-12. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00585117?
The interventions under investigation include: PET Imaging (PROCEDURE), PET imaging (PROCEDURE), PET-imaging with CuATSM (PROCEDURE), PET CuATSM (PROCEDURE), PET imaging with CuATSM (PROCEDURE).
Who is sponsoring clinical trial NCT00585117?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00585117's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia